Drug Shortage Report for INCRUSE ELLIPTA

Last updated on 2023-01-04 History
Report ID 178691
Drug Identification Number 02423596
Brand name INCRUSE ELLIPTA
Common or Proper name umeclidinium (as bromide) dry powder for oral inhalation
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) UMECLIDINIUM
Strength(s) 62.5MCG
Dosage form(s) POWDER
Route of administration INHALATION INHALATION
Packaging size 1x30
ATC code R03BB
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-12-12
Estimated end date 2023-01-06
Actual end date 2023-01-03
Shortage status Resolved
Updated date 2023-01-04
Company comments Managing supply due to high demand.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2023-01-04 French Compare
v3 2023-01-04 English Compare
v2 2022-12-16 French Compare
v1 2022-12-16 English Compare

Showing 1 to 4 of 4